OXGENE
OXGENE, a WuXi Advanced Therapies company, accelerates the delivery of gene therapy and biologics with its scalable gene therapy technologies and advanced CRISPR engineering platforms, facilitating breakthroughs in genetics and biopharmaceutical development.Content by OXGENE
Filter by
AllArticlesAudioEbooksEventsInfographicsNewsProductsSurveysDocumentsVideosVirtual EventsWebinars
Acquisition enables WuXi AppTec to offer its customers end-to-end support in the creation and development of cutting-edge cell and gene therapies for patients in need worldwide
| 2 min read
Paper demonstrates compatibility with downstream manufacturing technologies to help accelerate CAR-T or antibody therapeutics development
| 2 min read
Page 1 of 1 - 2 Total Items
